Evaluating Off-label Use of Direct Oral Anticoagulants (DOACs) in Hypercoagulable States

Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice

NCT00922766 ·Status: COMPLETED

Prophylactic Anticoagulation for Catheter-related Thrombosis

NCT04256525 ·Status: UNKNOWN ·Phase: PHASE4

Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam

NCT07083609 ·Status: RECRUITING

Patient-Centered Anticoagulation Self-Monitoring in Minority Patients

NCT02776566 ·Status: COMPLETED ·Phase: NA

Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2

NCT02371070 ·Status: COMPLETED

Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin

NCT00618579 ·Status: COMPLETED ·Phase: PHASE1

Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics

NCT01210755 ·Status: COMPLETED ·Phase: PHASE4

Precision Medicine Platform for Novel Oral Anticoagulants

NCT04056143 ·Status: UNKNOWN

DOAC ADRs Retrospective Study on Genetic Variations

NCT04580589 ·Status: COMPLETED

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

NCT04979780 ·Status: COMPLETED

D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD

NCT03261284 ·Status: UNKNOWN ·Phase: NA

Anticoagulation in Cancer Related Stroke

NCT02743052 ·Status: UNKNOWN

DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers

NCT05750680 ·Status: ACTIVE_NOT_RECRUITING

COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection

NCT04787510 ·Status: COMPLETED

A Prospective Pharmacodynamic Study of Dabigatran

NCT01588327 ·Status: COMPLETED

Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities

NCT00628576 ·Status: COMPLETED ·Phase: PHASE3

Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography

NCT02448901 ·Status: UNKNOWN

Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis

NCT00005684 ·Status: COMPLETED

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

NCT01999179 ·Status: COMPLETED ·Phase: NA

Heparin Versus Normal Saline in Peripherally Inserted Central Catheter Lines

NCT05029596 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients

NCT04593654 ·Status: COMPLETED

Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy

NCT01033279 ·Status: COMPLETED ·Phase: NA

Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke

NCT06292117 ·Status: RECRUITING

Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era

NCT05028777 ·Status: RECRUITING

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin

NCT02206087 ·Status: COMPLETED ·Phase: PHASE1/PHASE2